The latest price target for Guardian Pharmacy Service (NYSE:GRDN) was reported by Truist Securities on November 15, 2024. The analyst firm set a price target for $24.00 expecting GRDN to rise to within 12 months (a possible 12.10% upside). 3 analyst firms have reported ratings in the last year.

The latest analyst rating for Guardian Pharmacy Service (NYSE:GRDN) was provided by Truist Securities, and Guardian Pharmacy Service maintained their buy rating.

There is no last upgrade for Guardian Pharmacy Service

There is no last downgrade for Guardian Pharmacy Service.

Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Guardian Pharmacy Service, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Guardian Pharmacy Service was filed on November 15, 2024 so you should expect the next rating to be made available sometime around November 15, 2025.

While ratings are subjective and will change, the latest Guardian Pharmacy Service (GRDN) rating was a maintained with a price target of $22.00 to $24.00. The current price Guardian Pharmacy Service (GRDN) is trading at is $21.41, which is out of the analyst’s predicted range.